More about

Retinal Disease

News
April 22, 2020
1 min read
Save

OCT has limited impact on technology-based eye care services protocols

The use of OCT during a technology-based eye care services examination did not improve diagnostic accuracy for glaucoma or retinal diseases, according to a study.

News
April 17, 2020
1 min read
Save

OCT angiography shows acute IOP changes after intravitreal injections

Repeated intravitreal injections may result in glaucomatous damage, according to research done at New York Eye and Ear Infirmary of Mount Sinai.

News
April 07, 2020
5 min watch
Save

VIDEO: Retina specialist updates Cleveland Clinic reaction to coronavirus

VIDEO: Retina specialist updates Cleveland Clinic reaction to coronavirus

Rishi P. Singh, MD, discusses how the Cole Eye Institute at the Cleveland Clinic in Ohio has been adapting to treat ophthalmology patients during the COVID-19 pandemic.

News
March 31, 2020
3 min read
Save

BLOG: What is focal choroidal excavation?

We have come to the third and final installment in our spontaneous series about outer retinal anomalies found on OCT: focal choroidal excavations.

News
March 05, 2020
1 min watch
Save

VIDEO: AI leads patients through head-mounted AMD test

VIDEO: AI leads patients through head-mounted AMD test

ATLANTA – Maculogix has taken the 45-pound tabletop dark adaptation testing device, AdaptDx, and turned it into a head-mounted technology managed by an onboard artificial intelligence technician called Theia.

News
February 21, 2020
4 min watch
Save

VIDEO: The e-health revolution in health care

VIDEO: The e-health revolution in health care

TREVISO, Italy — At the Retina 2020: New Trends meeting, Claudio Azzolini, MD, speaks about e-health and the many opportunities it provides for more equal and accessible health care. Several universities in Italy and other European countries are involved in e-health projects.

News
January 31, 2020
1 min read
Save

FDA grants rare pediatric disease designation for QR-421a in retinitis pigmentosa

QR-421a has received rare pediatric disease designation from the FDA for the treatment of retinitis pigmentosa, according to a press release from ProQR Therapeutics.

News
January 17, 2020
1 min read
Save

Adverum reports significant progress with intravitreal gene therapy program

Adverum Biotechnologies has made significant progress in its lead clinical program for intravitreal gene therapy for retinal diseases, Leone Patterson, CEO and president, said at the J.P. Morgan Healthcare Conference.

News
January 16, 2020
1 min read
Save

Glaukos leverages acquisitions to enter new ophthalmology spaces

With recent acquisitions, Glaukos now has multiple products in development that expand its reach outside of the glaucoma space and into more comprehensive ophthalmology, CEO Tom Burns said at the J.P. Morgan Healthcare Conference.

News
January 14, 2020
1 min read
Save

Santen plans entry in US glaucoma market

Santen plans to break into the U.S. glaucoma market in 2020 with the introduction of the DE-128 microshunt, according to a speaker at the 38th annual J.P. Morgan Healthcare Conference.

View more